{"record_type":"pith_number_record","schema_url":"https://pith.science/schemas/pith-number/v1.json","pith_number":"pith:2026:6RA7CANSITSE6ZYUZLVKRMJP3L","short_pith_number":"pith:6RA7CANS","schema_version":"1.0","canonical_sha256":"f441f101b244e44f6714caeaa8b12fdac1e93412f61a3513cf677a403c160cca","source":{"kind":"arxiv","id":"2605.13786","version":1},"attestation_state":"computed","paper":{"title":"Interpretable Machine Learning for Antepartum Prediction of Pregnancy-Associated Thrombotic Microangiopathy Using Routine Longitudinal Laboratory Data","license":"http://creativecommons.org/licenses/by-nc-nd/4.0/","headline":"Gradient boosting on routine longitudinal lab tests predicts pregnancy-associated thrombotic microangiopathy risk with AUROC 0.872.","cross_cats":[],"primary_cat":"cs.LG","authors_text":"Chuanchuan Sun, Feng Yu, Qin Fan, Qingchao Chen, Zhen Yu","submitted_at":"2026-05-13T17:07:00Z","abstract_excerpt":"Background: Pregnancy-associated thrombotic microangiopathy (P-TMA) is rare but life-threatening. Early risk prediction before overt clinical presentation remains challenging, as the associated laboratory abnormalities are subtle, multidimensional, and frequently masked by common physiological changes such as gestational thrombocytopenia and pregnancy-related proteinuria, thus overlapping heavily with benign obstetric and renal conditions. This complexity is poorly captured by univariate or rule-based approaches; however, it is addressable by machine learning, which can extract latent, time-de"},"verification_status":{"content_addressed":true,"pith_receipt":true,"author_attested":false,"weak_author_claims":0,"strong_author_claims":0,"externally_anchored":false,"storage_verified":false,"citation_signatures":0,"replication_records":0,"graph_snapshot":true,"references_resolved":true,"formal_links_present":false},"canonical_record":{"source":{"id":"2605.13786","kind":"arxiv","version":1},"metadata":{"license":"http://creativecommons.org/licenses/by-nc-nd/4.0/","primary_cat":"cs.LG","submitted_at":"2026-05-13T17:07:00Z","cross_cats_sorted":[],"title_canon_sha256":"4264d0f3d44c7c3587fcbadcf6184e981f1490439f290b1f0ddccb8667e8c642","abstract_canon_sha256":"c6a3ad06d4aa1d9f59e71ae90ca58b0f0ac177bff758c0a3c3bd334587316a3e"},"schema_version":"1.0"},"receipt":{"kind":"pith_receipt","key_id":"pith-v1-2026-05","algorithm":"ed25519","signed_at":"2026-05-18T02:44:15.686128Z","signature_b64":"34NEsqm6Kpg6PeBgKLsrk6rUQ7K2tWxszRyKrJUht0Xn9f5xlnsaU7sxHgkZAKAKpDNnVqWKMh8TQSAhGZP4Aw==","signed_message":"canonical_sha256_bytes","builder_version":"pith-number-builder-2026-05-17-v1","receipt_version":"0.3","canonical_sha256":"f441f101b244e44f6714caeaa8b12fdac1e93412f61a3513cf677a403c160cca","last_reissued_at":"2026-05-18T02:44:15.685656Z","signature_status":"signed_v1","first_computed_at":"2026-05-18T02:44:15.685656Z","public_key_fingerprint":"8d4b5ee74e4693bcd1df2446408b0d54"},"graph_snapshot":{"paper":{"title":"Interpretable Machine Learning for Antepartum Prediction of Pregnancy-Associated Thrombotic Microangiopathy Using Routine Longitudinal Laboratory Data","license":"http://creativecommons.org/licenses/by-nc-nd/4.0/","headline":"Gradient boosting on routine longitudinal lab tests predicts pregnancy-associated thrombotic microangiopathy risk with AUROC 0.872.","cross_cats":[],"primary_cat":"cs.LG","authors_text":"Chuanchuan Sun, Feng Yu, Qin Fan, Qingchao Chen, Zhen Yu","submitted_at":"2026-05-13T17:07:00Z","abstract_excerpt":"Background: Pregnancy-associated thrombotic microangiopathy (P-TMA) is rare but life-threatening. Early risk prediction before overt clinical presentation remains challenging, as the associated laboratory abnormalities are subtle, multidimensional, and frequently masked by common physiological changes such as gestational thrombocytopenia and pregnancy-related proteinuria, thus overlapping heavily with benign obstetric and renal conditions. This complexity is poorly captured by univariate or rule-based approaches; however, it is addressable by machine learning, which can extract latent, time-de"},"claims":{"count":4,"items":[{"kind":"strongest_claim","text":"Gradient boosting was selected by cross-validation; the model achieved an AUROC of 0.872 (95% CI: 0.769-0.952) and AUPRC of 0.883 (95% CI: 0.780-0.959) in the held-out test cohort, with sensitivity 0.750 and specificity 0.812.","source":"verdict.strongest_claim","status":"machine_extracted","claim_id":"C1","attestation":"unclaimed"},{"kind":"weakest_assumption","text":"That the single-center retrospective cohort of 300 pregnancies is representative of future patients and that the held-out test performance will generalize without external validation or prospective testing.","source":"verdict.weakest_assumption","status":"machine_extracted","claim_id":"C2","attestation":"unclaimed"},{"kind":"one_line_summary","text":"Gradient boosting on 146 longitudinal lab predictors from routine prenatal care achieves AUROC 0.872 on held-out test data for antepartum P-TMA risk prediction.","source":"verdict.one_line_summary","status":"machine_extracted","claim_id":"C3","attestation":"unclaimed"},{"kind":"headline","text":"Gradient boosting on routine longitudinal lab tests predicts pregnancy-associated thrombotic microangiopathy risk with AUROC 0.872.","source":"verdict.pith_extraction.headline","status":"machine_extracted","claim_id":"C4","attestation":"unclaimed"}],"snapshot_sha256":"ae7b240330a0afb2e2926edd5cadcdbadff79e5b20c0fb01041448b3972185bc"},"source":{"id":"2605.13786","kind":"arxiv","version":1},"verdict":{"id":"191b6187-8245-4691-8ae1-04c5a350eced","model_set":{"reader":"grok-4.3"},"created_at":"2026-05-14T19:12:24.161586Z","strongest_claim":"Gradient boosting was selected by cross-validation; the model achieved an AUROC of 0.872 (95% CI: 0.769-0.952) and AUPRC of 0.883 (95% CI: 0.780-0.959) in the held-out test cohort, with sensitivity 0.750 and specificity 0.812.","one_line_summary":"Gradient boosting on 146 longitudinal lab predictors from routine prenatal care achieves AUROC 0.872 on held-out test data for antepartum P-TMA risk prediction.","pipeline_version":"pith-pipeline@v0.9.0","weakest_assumption":"That the single-center retrospective cohort of 300 pregnancies is representative of future patients and that the held-out test performance will generalize without external validation or prospective testing.","pith_extraction_headline":"Gradient boosting on routine longitudinal lab tests predicts pregnancy-associated thrombotic microangiopathy risk with AUROC 0.872."},"references":{"count":3,"sample":[{"doi":"","year":2024,"title":"Thrombotic microangiopathy in pregnancy: Current understanding and management strategies[J]","work_id":"5aadc0ac-fe44-47b0-b637-27f01dc71df0","ref_index":1,"cited_arxiv_id":"","is_internal_anchor":false},{"doi":"","year":2024,"title":"Machine learning models for predicting preeclampsia: A systematic review[J]","work_id":"96e87f3c-216b-458b-9c08-9eb09b94acde","ref_index":2,"cited_arxiv_id":"","is_internal_anchor":false},{"doi":"","year":2013,"title":"Cystatin C versus creatinine in determining risk based on kidney function[J]","work_id":"7331c53e-2ce1-4f7e-8e64-52fa83e8cdc8","ref_index":3,"cited_arxiv_id":"","is_internal_anchor":false}],"resolved_work":3,"snapshot_sha256":"ada3a8ccfb90f3a2c958653f52bcf11dcb37fec794acd74f94191576a64e38e9","internal_anchors":0},"formal_canon":{"evidence_count":0,"snapshot_sha256":"258153158e38e3291e3d48162225fcdb2d5a3ed65a07baac614ab91432fd4f57"},"author_claims":{"count":0,"strong_count":0,"snapshot_sha256":"258153158e38e3291e3d48162225fcdb2d5a3ed65a07baac614ab91432fd4f57"},"builder_version":"pith-number-builder-2026-05-17-v1"},"aliases":[{"alias_kind":"arxiv","alias_value":"2605.13786","created_at":"2026-05-18T02:44:15.685725+00:00"},{"alias_kind":"arxiv_version","alias_value":"2605.13786v1","created_at":"2026-05-18T02:44:15.685725+00:00"},{"alias_kind":"doi","alias_value":"10.48550/arxiv.2605.13786","created_at":"2026-05-18T02:44:15.685725+00:00"},{"alias_kind":"pith_short_12","alias_value":"6RA7CANSITSE","created_at":"2026-05-18T12:33:37.589309+00:00"},{"alias_kind":"pith_short_16","alias_value":"6RA7CANSITSE6ZYU","created_at":"2026-05-18T12:33:37.589309+00:00"},{"alias_kind":"pith_short_8","alias_value":"6RA7CANS","created_at":"2026-05-18T12:33:37.589309+00:00"}],"events":[],"event_summary":{},"paper_claims":[],"inbound_citations":{"count":0,"internal_anchor_count":0,"sample":[]},"formal_canon":{"evidence_count":0,"sample":[],"anchors":[]},"links":{"html":"https://pith.science/pith/6RA7CANSITSE6ZYUZLVKRMJP3L","json":"https://pith.science/pith/6RA7CANSITSE6ZYUZLVKRMJP3L.json","graph_json":"https://pith.science/api/pith-number/6RA7CANSITSE6ZYUZLVKRMJP3L/graph.json","events_json":"https://pith.science/api/pith-number/6RA7CANSITSE6ZYUZLVKRMJP3L/events.json","paper":"https://pith.science/paper/6RA7CANS"},"agent_actions":{"view_html":"https://pith.science/pith/6RA7CANSITSE6ZYUZLVKRMJP3L","download_json":"https://pith.science/pith/6RA7CANSITSE6ZYUZLVKRMJP3L.json","view_paper":"https://pith.science/paper/6RA7CANS","resolve_alias":"https://pith.science/api/pith-number/resolve?arxiv=2605.13786&json=true","fetch_graph":"https://pith.science/api/pith-number/6RA7CANSITSE6ZYUZLVKRMJP3L/graph.json","fetch_events":"https://pith.science/api/pith-number/6RA7CANSITSE6ZYUZLVKRMJP3L/events.json","actions":{"anchor_timestamp":"https://pith.science/pith/6RA7CANSITSE6ZYUZLVKRMJP3L/action/timestamp_anchor","attest_storage":"https://pith.science/pith/6RA7CANSITSE6ZYUZLVKRMJP3L/action/storage_attestation","attest_author":"https://pith.science/pith/6RA7CANSITSE6ZYUZLVKRMJP3L/action/author_attestation","sign_citation":"https://pith.science/pith/6RA7CANSITSE6ZYUZLVKRMJP3L/action/citation_signature","submit_replication":"https://pith.science/pith/6RA7CANSITSE6ZYUZLVKRMJP3L/action/replication_record"}},"created_at":"2026-05-18T02:44:15.685725+00:00","updated_at":"2026-05-18T02:44:15.685725+00:00"}